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Abstract
Background Personal protection equipment, improved
early medical care, and rapid extraction of the casualty
have resulted in more injured service members who served
in Afghanistan surviving after severe military trauma.
Many of those who survive the initial trauma are faced with
complex wounds such as multiple amputations. Although
costs of care can be high, they have not been well quan-
tified before. This is required to budget for the needs of the
injured beyond their service in the armed forces.
Question/purposes The purposes of this study were (1) to
quantify and describe the extent and nature of traumatic
amputations of British service personnel from Afghanistan;
and (2) to calculate an estimate of the projected long-term
cost of this cohort.
Methods A four-stage methodology was used: (1) sys-
tematic literature search of previous studies of amputee
care cost; (2) retrospective analysis of the UK Joint Theatre
Trauma and prosthetic database; (3) Markov economic
algorithm for healthcare cost and sensitivity analysis of
results; and (4) statistical cost comparison between our
cohort and the identified literature.
Results From 2003 to 2014, 265 casualties sustained 416
amputations. The average number of limbs lost per casualty
was 1.6. The most common type of amputation was a
transfemoral amputation (153 patients); the next most
common amputation type was unilateral transtibial (143
patients). Using a Markov model of healthcare economics,
it is estimated that the total 40-year cost of the UK
Afghanistan lower limb amputee cohort is £288 million
(USD 444 million); this figure estimates cost of trauma
care, rehabilitation, and prosthetic costs. A sensitivity
analysis on our model demonstrated a potential ± 6.19%
variation in costs.
Conclusions The conflict in Afghanistan resulted in high
numbers of complex injuries. Our findings suggest that a
long-term facility to budget for veterans’ health care is
necessary.
Clinical Relevance Estimates here should be taken as the
start of a challenge to develop sustained rehabilitation and
recovery funding and provision.
Introduction
The year 2014 saw the wind down and withdrawal of
British troops from Afghanistan; over the past 2 years,
military operations have progressively been handed over to
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the Afghan security forces. It is now well documented that
the conflict is associated with casualties surviving highly
complex military-related trauma. This has been attributed
to improved personal protection equipment, improved on-
the-ground medical care, and rapid extraction of the ca-
sualty [3, 7]. However, one consequence of the complexity
of the wounds is illustrated by the resulting multiple am-
putees [2].
Previous studies have provided snapshots of the mag-
nitude of the amputee figures from military operations in
Afghanistan but with the draw down, only now is the
complete size of the amputee cohort evident [8, 10].
Medical care and research is now focused on the long-term
care of our injured service personnel as well as capturing
the lessons learned from Afghanistan and through research
and training ensuring that this is not lost. With evidence
from Vietnam [11] suggesting that medical and reha-
bilitative needs extend beyond 25 years after injury, we
have an imperative to assess the magnitude of the amputee
cohort and the long-term health economics for provision of
care for contemporary casualties. An accurate description
of the casualty statistics is necessary to calculate healthcare
spending and long-term care costs to aid the healthcare
policy decision-making process.
The purpose of this study is twofold. First it is necessary
to quantify and qualify the extent and nature of all trauma-
related amputations from Afghanistan. This will provide us
with a compete profile of the amputee cohort detailing the
exact injuries sustained. Second, using these data, and after
examining published work on long-term care of amputees
and mathematical algorithms of health economics, we aim
to estimate the projected long-term cost of the Afghanistan
amputation cohort from the perspective of the healthcare
provider, the National Health Service.
Materials and Methods
The study was conducted in a stepwise manner (Fig. 1).
Patients with trauma-related amputations were identified
from the definitive database, based at Headley Court, used
for prosthetic fitting, and the Joint Theatre Trauma data-
base based at the Royal Centre for Defence Medicine. Data
extracted included number of amputations, locations and
level of amputations, and date of injury. After testing for
normality, statistical analysis was performed using Stu-
dent’s t-test and Mann-Whitney U test and chi-square test
where appropriate using SPSS statistics Version 20.1
(SPSS Inc, Chicago, IL, USA) with significance set at
p\ 0.05.
A Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) type search was performed
using the OvidSP platform using two separate search re-
sources (PubMed/MEDLINE and Embase) to identify
research articles that calculate and explain in economic
terms the cost of rehabilitation of amputees [19]. Articles
in both the civilian and military setting were examined.
This database was searched for references using the search
terms ‘‘Amputee’’, ‘‘rehabilitation’’, and ‘‘cost’’ as key-
words. Primary and secondary exclusion criteria were then
used to filter the results. Primary exclusions included au-
diovisual, lecture, book, and biography publications.
Secondary exclusions included letters, retracted articles,
comments, editorials, and conference papers. Manual
strategies subsequently used to establish relevance were (1)
title review; (2) Medical Subject Headings [17] term re-
view; (3) abstract review; and finally (4) full article review.
Papers detailing cost analyses of the long-term cost of
amputee rehabilitation were evaluated and a comparison of
their findings made providing the authors revealed specific
Fig. 1 A flowchart demonstrating the study process used during the research.
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costs of prosthetic care and examined or performed a
sensitivity analysis, long-term costs, and tolerances in their
economic findings.
The Markov model of economic evaluation of health
uses both resource management and health outcome con-
sequences from medical intervention. Markov models
represent a stochastic process used in the economic eval-
uation of health and disease [5]. They are used by health
economists in the calculation of cost of health care and
intervention, particularly in chronic disease. In this model
the economics relating to death from disease, disease
progression, effectiveness of treatment, and natural death
risk are applied to annual cycles of care as the patient ages.
An adapted Markov model algorithm was used to calculate
the cost of rehabilitation and prosthetic costs on an as-
sumed average patient in our amputee cohort in the British
market. In our Markov decision tree, the decision to treat
arm is replaced with actual treatment in the form of fitting a
new prosthetic device. Prosthetics costs were cycled every
2.3 years and run in parallel with 1-year Markov cycles
(Fig. 2). Only direct costs relating to prosthetics, consum-
ables and related clinical activities were considered. Model
assumptions such as time horizon (40 years), prosthetic
costs, and prosthetic cycle length (2.3 years) were derived
from our literature review of amputee health economics [4,
9, 16]. Where probabilistic assumptions necessary for the
model (such as probability of wound complications, likely
timing of chronic diseases, frequency of clinic visits, pro-
jected prosthetic advancements, and subsequent additional
replacements) were not available, coauthors were consulted
whose specialist fields include orthopaedic surgeons (DSE,
JCC), a rehabilitation physician (RDP), an economist (NB),
and a bioengineering expert (AMJB). The cost increase per
year per casualty was calculated and extrapolated every
year for 5 years, then at 5-year intervals until 40 years after
the injurious event. A calculation of total cost of the entire
cohort was then made using historical economic data from
the Bank of England [1]; the costs among studies were
normalized for exchange rate and inflation variable. The
results from the cost analysis were then compared with the
financial findings from the literature search previously
performed. Statistical analysis was performed using Pear-
son’s correlation coefficient to examine the extent of a
linear relationship between the literature and this work
using SPSS statistics Version 20.1 with significance set at
p\ 0.05.
Finally, a sensitivity analysis was performed in an at-
tempt to present the potential extremes of valuations and
therefore the errors in any assumptions made. Varying
prosthetic use and an equal probability of each transition
state (health, chronic health, death) of 0.33 was added to
our model [4–6]. TreeAge Pro Healthcare 2015 software
(TreeAge Software Inc, Williamstown, MA, USA) was
used in our model-making and simulations.
Fig. 2A–B A Markov decision
tree demonstrating the difference
in the chronic health profile of
(A) the normal population and
(B) the military amputee cohort
described in this work.
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Results
Extent and Nature of Amputations From British
Operations in Afghanistan
From 2003 to October 2014, 265 casualties sustained a
total of 416 amputations either at the point of wounding or
subsequent to wounds (Table 1). As a result of small ca-
sualty figures on the triple and quadruple amputee group,
data have been compressed to ‘‘Triple +’’ to prevent the
likelihood of an individual being identified and compro-
mising his or her right to medical confidentiality.
The mean number of limbs lost per casualty was 1.6
(SD ± 0.68) with a mean range of one in 2006 to 1.7 in
2010. The most common injury pattern per casualty seen
was that of a single amputation. When limbs lost per injury
type were analyzed, double amputations were the most
common. The crossover between single and double am-
putations occurred at the end of 2008.
The most common level of amputation was transfemoral
totaling 153 patients followed by 143 transtibial amputa-
tions with peak incidence of both seen in 2010. Single
amputations were more likely to be associated with
transtibial-level injuries (89 patients out of 140 single
amputations), whereas transfemoral amputations were most
common in double and triple amputees (134 amputations
out of 268 limbs lost). Other levels seen were hind or
forequarter, through-knee or knee disarticulation, and foot
amputations. When further analyzing double amputees, the
most common patterns of injury seen were that of a
transfemoral-transfemoral casualty (38 patients out of a
total 101 double amputees). Numbers were not sufficient to
test this statistically.
Long-term Costs of Amputee Care
We calculate the long-term cost of the UK Afghanistan
lower limb amputee cohort only to be £288 million (USD
444 million) in today’s currency.
After removal of duplications from the literature search,
we have referred to three papers (Blough et al. [4], Chung
et al. [9], and Hertel et al. [16]) to fully detail the entire
expected financial implication of trauma-related amputa-
tions (Table 2; Fig. 3).
Blough et al. [4] estimated the prosthetic cost and care
for service men and women with major limb loss
specifically related to veterans of Iraq and Afghanistan,
Operation Iraqi Freedom (OIF), and Operation Enduring
Freedom (OEF). They assessed unilateral upper limb,
unilateral lower limb, bilateral upper limb, and multiple
limbs. An assembled team of experts processed data col-
lected from a total of 283 veterans using MediCare 2005
prosthetic costing and Markov model analysis. They cal-
culated that in 2010 the 5-year and lifetime cost range for
each group was USD 0.11 million and USD 0.82 million
(unilateral upper limb), USD 0.23 million and USD 1.46
million (unilateral lower limb), USD 0.33 million and USD
2.12 million (bilateral upper limb), and USD 0.45 million
and USD 2.90 million (multiple limbs).
Within the civilian trauma setting, both Hertel et al. [16]
and Chung et al. [9] sought to formulate the cost of am-
putation care. Both papers compare amputations with
reconstruction/salvage in severe fractures of the lower
limb. Hertel et al.’s [16] paper from 1996 comments that
the second and fourth year mean annual cost for the care of
the amputee was 24,824 Swiss Francs (SF) and 15,112 SF,
respectively. Using Bank of England archives of historic
Table 1. Total amputations per year and type
Year Single Double Triple+ Total Total
number
of limbs
2006 # # #
2007 9 # #
2008 19 7 #
2009 20 17 #
2010 34 32 9
2011 30 20 7
2012 15 20 #
2013 7 # #
2014 # # #
Total 140 101 24 265 416
Data presented as ‘‘#’’ has been suppressed in accordance with De-
fence Statistics rounding policy and medical confidentiality.
Table 2. A summary of papers relevant to actual cost of amputee care
Study Year Patient group Time scale Comparative study
Hertel et al. [16] 1996 Civilian trauma 2–4 years Amputation versus reconstruction
Chung et al. [9] 2009 Civilian trauma 2 years to lifetime Amputation versus salvage
Blough et al. [4] 2010 Military trauma (OIF/OEF) 5, 10, 20 years and lifetime Vietnam versus OIF/OEF
OIF = Operation Iraqi Freedom; OEF = Operation Enduring Freedom.
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exchange rates and the Bank of England Inflation Calcu-
lator [1], this amounts to annual cost in 2012 of £104,609
(USD 161,350) and £63,679 (USD 98,219), respectively.
Chung et al.’s [9] data were in a contemporaneous co-
hort of patients and data extracted from the Lower
Extremity Assessment Project (LEAP), a multicenter
prospective outcome study examining severe limb-threat-
ening injuries, detailed prosthetic, and nonprosthetic costs.
They described the cost to the taxpayer in 2009 for the care
of amputees to significantly reduce after 2 years, from a
total of approximately USD 91,000 for the first 2 years
followed by annual ongoing costs of USD 3700 thereafter
for life with an additional USD 10,200 every 2 years for
additional prosthetics. This equates to a total of £27,000
(USD 45,500) annually for the first 2 years and a total of
£69,000 (USD 117,400) for the first 5 years of care. We
compared costs as estimated by the three papers we in-
cluded based on our systematic review [4, 9, 16] and found
no differences between them (p = 0.19).
Following Markov model calculations, no statistical dif-
ferences could be found between our results and published
figures in the first 5 years of care, and as a consequence,
costing can be considered comparative (Fig. 4).
Blough et al. [4] calculated lifetime cost. Their model
suggested that 40 cycles, or years, after the initial injury
was an adequate mean point for life expectancy of the
cohort taking into account chronic health of a normal
population. The healthcare costs of amputees calculated in
the searched papers were also extrapolated to the 40-year
point described by Blough et al. (Fig. 5). Final discrepancy
in the model here and other figures may reflect the addi-
tional costs of chronic disease of age, which are factored in
the Markov model. Although a major difference in the
endpoint figures are seen between Blough et al.’s [4] data
and Chung et al.’s [9] work, no difference exists between
the data presented here and other figures.
Using data collected in the first part of the study and
estimated costs from the economic model findings, entire
lower limb amputee cohort long-term costs were subse-
quently calculated. Based on limb prosthetic costs from
Blough et al.’s [4] paper, a single tibial prosthetic cost was
£9946 (USD 16,690), a knee prosthesis was £27,154 (USD
56,563), a femoral prosthesis was £27,154 (USD 45,563),
and a foot prosthesis was £9747 (USD 14,187). Therefore,
the base cost over 40 years of single amputees was £0.87
million (USD 1.34 million) for a transtibial amputee, £1.16
million (USD 1.79 million) for a through-knee amputee,
Fig. 4 A graph of the projected
5-year costs of amputee health-
care demonstrating the data
published in the literature com-
pared with the simplified UK
cohort Markov model construct-
ed during our research.
Fig. 3 The flowchart systematic review process was used to filter
articles found during the literature search.
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and £1.16 million (USD 1.79 million) for a transfemoral
amputee. Additional limb 40-year costs, as seen in double
amputations, were calculated as £0.16 million (USD 0.25
million) for a tibial component, £0.45 million (USD 0.69
million) for a through-knee prosthesis, and £0.45 million
(USD 0.69 million) for a femoral prosthesis. Therefore,
total 40-year costs for double and triple amputees (upper
limb not taken into account) are £1.03 million (USD 1.59
million) for a double transtibial, £1.32 million (USD 2.04
million) for transtibial-through knee/transfemoral, and
£1.60 million (USD 2.47 million) for a double through-
knee/transfemoral.
The sensitivity analysis on our decision-making tree, if
‘‘worst case’’ scenario of equal transition probability is
assumed, a variation of ± 6.19% of our total figure is
possible if prosthetic change requirements were adjusted
from every 2 years to 5 years form the calculated
2.3 years. This resulted in a variation of +2.99% to
10.75% in the overall costs in prosthetics alone.
Discussion
The hallmark of the wounded legacy from Afghanistan is
that of the traumatic amputee. This is likely to be the result
of the fact that the improvised explosive device has become
the weapon of choice against coalition forces by insurgent
groups. With an increase in casualty numbers from this
type of weapon as a result of improved casualty evac-
uation, medical treatment, and personal equipment, large
cohorts of severely injured service personnel are returning
home requiring multidisciplinary care in the short and long
term. In this article, our aim was to formalize our casualty
figures that fall into this group and attempt to calculate the
cost of their care for future policymaking decisions.
Specific limitations include the small number of suitable
publications encountered in our systematic review to guide
the analysis. This is the result of the fact that in the civilian
setting, trauma-related amputations remain relatively un-
common with peripheral vascular disease and diabetic
complications the leading cause of amputation in the de-
veloped world. As a consequence, only two papers
pertaining to the cost of care of civilian amputees could be
used in our analysis [9, 16]. In addition to this, uncertainty
on the actual cost of care will undoubtedly result in var-
iation of our calculations. Some of our figures used were
costs calculated in the United States, where a larger market
drives prices. It is recognized that a 29%difference in price is
seen between private and state-funded care [15]. Equally,
consumable discounted rates, the effect of inflation, and
exchange rate all play a part in producing an error in readings
[12]. An assumption that all lower limb amputees would use
prosthetics was made. This, however, as demonstrated by
Dougherty et al. [11], is not always the case. Costs incurred
by a wheelchair user are not negligible; wheelchair types
(transit, electric, narrow, prescriptive), house modification,
annual servicing, replacement, and caregiver for self-pro-
pelled wheelchairs all contribute to costs of care but were not
considered in our analysis. Another confounding factor
leading to variations in cost is the chronic disease profile of
our veterans. It is possible and likely, but currently unknown,
that the increased complexity of injuries seen in our cohort
will result in different long-term health profiles, including
death rate, than that of the general population that the Mar-
kov model used relied on. When compared with published
data about civilian populations, gender, age, and physical
activity in military populations will also demonstrate dif-
fering pathological profiles with time. The rehabilitation
of amputees from a veteran cohort does not remain within
the remit of musculoskeletal medicine and represents the
‘‘tip of the iceberg’’ concept where primary injury results
in chronic health issues [13, 14]. Polytrauma, traumatic
brain injury, and posttraumatic stress disorder are dis-
cussed as the primary medical issues, whereas limited
mobility, weight gain, diabetes mellitus, coronary artery
disease, chronic obstructive pulmonary disease, and liver
failure are secondary/tertiary sequelae of the primary in-
sult. The timeframe of disease progression was to 2035.
The subsequent chronic health issues are not considered
by the Blough group [4].
The Markov model as set out works on variables and
policies on a no-change basis and these generate a certain
level of costs. The costs generated are comparable with
those in US studies as well as with those in the only pre-
vious UK study. However, we should stress that the costs
do not cover the costs of any comorbidity or treatment,
which may be required for other illness in the future nor do
they cover the economic losses that would result if patients
have to drop out of the workforce. The altered chronic
health profile is described and hypothesized by Geiling
et al. [14]. Technological advances in the expanding field
Fig. 5 A graph of the projected 40-year costs of amputee health care
demonstrating the data published in the literature compared with the
simplified UK cohort Markov model constructed during our research.
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of prosthetic use will also have an impact on the cost of
care. It would be realistic to assume that including addi-
tional treatment cost and economic losses, the total cost or
‘‘disease burden’’ would be much higher than £288 million
(USD 444 million) over 40 years; for example, upper limb
provision was not included as a result of multiple unknown
factors (future costs, future technological advancements,
long-term use) and, as a consequence, an uplift in final
expenditure would also be expected if included. Our esti-
mates here should be taken as the start of a challenge to
develop sustained rehabilitation and recovery funding and
provision. To fully appreciate the long-term health conse-
quences of the modern-day military blast victim, a
longitudinal study of all amputees must be performed.
When compared with previously published work [8] of
the experience in Iraq and the early Afghanistan years, our
data show that casualties from Afghanistan to have a
greater number and a higher level of amputation. This has
been alluded to in earlier research [10], but our findings
represent a complete cohort of casualties from the entire
date range. The heterogeneous nature of warfare results in
the variation of statistics seen. Obvious confounding fac-
tors to our data include change in standard operating
procedures (militarily and medically), change in tactics by
the insurgents, equipment improvements, and vehicle fac-
tors. The resulting medical and rehabilitation legacy is
clear with 265 amputees requiring long-term medical care.
We have attempted to place a figure on the financial burden
of care for our cohort.
Using published data and an economic algorithm for
healthcare costs, we have estimated that over 40 years, £288
million (USD 444 million) will be required to care for our
veterans. This is less, per amputee, than calculated for US
veterans [4] but more than the cost calculated for civilian
trauma amputees investigated in the LEAP study. Historical
data collected in 1965 at the Dundee Limb Fitting Centre for
98 veterans of the two world wars and Korean operations
revealed on average £9952 (USD 15,350) (data collected in
1965 and published 1999) per limbless servicemen over their
lifetime [18]. If we were to extrapolate individual figures for
this historical cohort, then the comparative cost, normalized
for inflation, is £0.17 million (USD 0.26 million) for life, the
lifetime cost of a single amputee. This is similar to values we
obtained of £0.16 million (USD 0.025 million) for a tibial
component and £0.45 million (USD 0.69 million) for a
femoral prosthesis.
The latter years of the conflict in Afghanistan resulted in
high numbers of casualties with multiple and complex in-
juries. Our findings suggest that a long-term facility to
budget for our veterans’ prosthetic needs is necessary.
Ongoing evaluation and assessment of our injured soldiers
will be required to assess the level and specialization of
care required as the population ages. It is likely that the
described cohort will be subjected to chronic health prob-
lems experienced by the general population as well as
specific issues as a result of their injuries. These results
could be modified if we can develop more effective and
sustained medical and social support postmilitary dis-
charge, which would encourage healthier lifestyles and
help people develop their skills and earning capacity. This
is only possible through long-term financial commitment to
health care, social services, and resources such as a single
point of care. The British military is embarking on a
20-year study, called the Armed Service Trauma Reha-
bilitation Outcome study, looking at the health and well-
being of amputees and veterans in a case-control cohort
study that should hopefully help answer these questions in
the future.
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